logo
Plus   Neg
Share
Email

Lululemon Athletica Boosts Q4 Outlook - Quick Facts

Athletic apparel company lululemon athletica inc. (LULU) on Monday raised its earnings and net revenue guidance for the fourth quarter of fiscal 2019, ending February 2, 2020, ahead of the ICR Conference later in the day.

For the fourth quarter, the company raised its earnings guidance to a range of $2.22 to $2.25 per share from the previous guidance range of $2.10 to $2.13 per share. Both based on a 28.5% effective tax rate.

The company also now projects net revenues for the quarter between $1.37 billion and $1.38 billion on a total comparable sales increase in the mid-to-high teens on a constant dollar basis, up from the prior forecast range of $1.315 billion to $1.330 billion on a total comparable sales increase in the low-double digits on a constant dollar basis.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.15 per share on revenues of $1.35 billion for the fourth quarter. Analysts' estimates typically exclude special items.

"We're excited by the momentum in our business over the holiday period with guests responding well to our innovative merchandise offering," said Calvin McDonald, CEO of lululemon.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT